Abstract
Adequate adherence to prescribed treatment regimens can help to break the cycle of treatment failure, disease progression and subsequent treatment escalation. Unfortunately, adherence in the treatment of skin disorders such as acne, atopic dermatitis/eczema and psoriasis is often inadequate. A review of the literature identified a number of studies that tested an intervention to improve adherence in dermatology, including the following: electronic messages and/or reminders; more frequent or ‘extra’ clinic visits; audio-visual and internet-based interventions; and patient support programmes and/or self-management, educational training programmes. While there is no one solution or action for improving adherence, some interventions were more successful than others. We provide practical guidance on how to support adherence based on aspects of the successful interventions identified and on our collective opinion and clinical practice experience. Holding patients accountable, providing a caring and supportive environment, raising awareness of poor adherence and helping patients build a solid medication-taking habit can help to improve adherence so that patients can experience maximal treatment benefits and desired clinical outcomes.
Similar content being viewed by others
References
National Institute for Health and Clinical Excellence. Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence CG76. 2009.
Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705. doi:10.1111/j.1365-2125.2012.04167.x.
Augustin M, Holland B, Dartsch D, Langenbruch A, Radtke MA. Adherence in the treatment of psoriasis: a systematic review. Dermatology. 2011;222(4):363–74. doi:10.1159/000329026.
Lott R, Taylor SL, O’Neill JL, Krowchuk DP, Feldman SR. Medication adherence among acne patients: a review. J Cosmet Dermatol. 2010;9(2):160–6. doi:10.1111/j.1473-2165.2010.00490.x.
Beattie PE, Lewis-Jones MS. Parental knowledge of topical therapies in the treatment of childhood atopic dermatitis. Clin Exper Dermatol. 2003;28(5):549–53.
Krejci-Manwaring J, Tusa MG, Carroll C, Camacho F, Kaur M, Carr D, et al. Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis. J Am Acad Dermatol. 2007;56(2):211–6. doi:10.1016/j.jaad.2006.05.073.
Santer M, Burgess H, Yardley L, Ersser SJ, Lewis-Jones S, Muller I, et al. Managing childhood eczema: qualitative study exploring carers’ experiences of barriers and facilitators to treatment adherence. J Adv Nurs. 2013;69(11):2493–501. doi:10.1111/jan.12133.
Saeki H, Imafuku S, Abe M, Shintani Y, Onozuka D, Hagihara A, et al. Poor adherence to medication as assessed by the Morisky Medication Adherence Scale-8 and low satisfaction with treatment in 237 psoriasis patients. J Dermatol. 2015;42(4):367–72. doi:10.1111/1346-8138.12804.
Furue M, Onozuka D, Takeuchi S, Murota H, Sugaya M, Masuda K, et al. Poor adherence to oral and topical medication in 3096 dermatological patients as assessed by the Morisky Medication Adherence Scale-8. Br J Dermatol. 2015;172(1):272–5. doi:10.1111/bjd.13377.
Devaux S, Castela A, Archier E, Gallini A, Joly P, Misery L, et al. Adherence to topical treatment in psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol JEADV. 2012;26(Suppl 3):61–7. doi:10.1111/j.1468-3083.2012.04525.x.
Dreno B, Thiboutot D, Gollnick H, Finlay AY, Layton A, Leyden JJ, et al. Large-scale worldwide observational study of adherence with acne therapy. Int J Dermatol. 2010;49(4):448–56. doi:10.1111/j.1365-4632.2010.04416.x.
Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47(6):555–67.
Stack RJ, Bundy C, Elliott RA, New JP, Gibson JM, Noyce PR. Patient perceptions of treatment and illness when prescribed multiple medicines for co-morbid type 2 diabetes. Diabetes Metab Syndr Obes Targets Ther. 2011;4:127–35. doi:10.2147/DMSO.S17444.
Horne R, Chapman SC, Parham R, Freemantle N, Forbes A, Cooper V. Understanding patients’ adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework. PLoS One. 2013;8(12):e80633. doi:10.1371/journal.pone.0080633.
Horne R. Representations of medication and treatment: advances in theory and measurement. In: Petrie KJ, Weinman JA, editors. Perceptions of health and illness: current research and applications. London: Harwood Academic Press; 1997. p. 155–88.
Horne R. Treatment perception and self regulation. In: Camerson LD, Leventhal H, editors. The self-regulation of health and illness behaviour. London: Routledge; 2003. p. 138–53.
Lee IA, Maibach HI. Pharmionics in dermatology: a review of topical medication adherence. Am J Clin Dermatol. 2006;7(4):231–6.
Tan X, Feldman SR, Chang J, Balkrishnan R. Topical drug delivery systems in dermatology: a review of patient adherence issues. Expert Opin Drug Deliv. 2012;9(10):1263–71. doi:10.1517/17425247.2012.711756.
Kardas P, Lewek P, Matyjaszczyk M. Determinants of patient adherence: a review of systematic reviews. Front Pharmacol. 2013;4:91. doi:10.3389/fphar.2013.00091.
Assawasuwannakit P, Braund R, Duffull SB. Quantification of the forgiveness of drugs to imperfect adherence. CPT Pharmacomet Syst Pharmacol. 2015;4(3):e00004. doi:10.1002/psp4.4.
Dusing R, Lottermoser K, Mengden T. Compliance with drug therapy-new answers to an old question. Nephrol Dial Transpl Off Publ Eur Dial Transpl Assoc Eur Renal Assoc. 2001;16(7):1317–21.
Carr A, Patel R, Jones M, Suleman A. A pilot study of a community pharmacist intervention to promote the effective use of emollients in childhood eczema. Pharm J. 2007;278:319–22.
Cork MJ, Britton J, Butler L, Young S, Murphy R, Keohane SG. Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. Br J Dermatol. 2003;149(3):582–9.
Mollerup A, Veien NK, Johansen JD. Effectiveness of the Healthy Skin Clinic–a randomized clinical trial of nurse-led patient counselling in hand eczema. Contact Dermat. 2014;71(4):202–14. doi:10.1111/cod.12243.
Moore EJ, Williams A, Manias E, Varigos G, Donath S. Eczema workshops reduce severity of childhood atopic eczema. Australas J Dermatol. 2009;50(2):100–6. doi:10.1111/j.1440-0960.2009.00515.x.
Pena-Robichaux V, Kvedar JC, Watson AJ. Text messages as a reminder aid and educational tool in adults and adolescents with atopic dermatitis: a pilot study. Dermatol Res Pract. 2010;2010. doi:10.1155/2010/894258.
Staab D, von Rueden U, Kehrt R, Erhart M, Wenninger K, Kamtsiuris P, et al. Evaluation of a parental training program for the management of childhood atopic dermatitis. Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol. 2002;13(2):84–90.
Yentzer BA, Camacho FT, Young T, Fountain JM, Clark AR, Feldman SR. Good adherence and early efficacy using desonide hydrogel for atopic dermatitis: results from a program addressing patient compliance. J Drugs Dermatology JDD. 2010;9(4):324–9.
Sagransky MJ, Yentzer BA, Williams LL, Clark AR, Taylor SL, Feldman SR. A randomized controlled pilot study of the effects of an extra office visit on adherence and outcomes in atopic dermatitis. Arch Dermatol. 2010;146(12):1428–30. doi:10.1001/archdermatol.2010.368.
Boker A, Feetham HJ, Armstrong A, Purcell P, Jacobe H. Do automated text messages increase adherence to acne therapy? Results of a randomized, controlled trial. J Am Acad Dermatol. 2012;67(6):1136–42. doi:10.1016/j.jaad.2012.02.031.
Eichenfield LF, Krakowski AC. A novel patient support program to address isotretinoin adherence: proof-of-concept analysis. J Drugs Dermatol JDD. 2015;14(4):375–9.
Fabbrocini G, Izzo R, Donnarumma M, Marasca C, Monfrecola G. Acne smart club: an educational program for patients with acne. Dermatology. 2014;229(2):136–40. doi:10.1159/000362809.
Navarrete-Dechent C, Curi-Tuma M, Nicklas C, Cardenas C, Perez-Cotapos ML, Salomone C. Oral and written counseling is a useful instrument to improve short-term adherence to treatment in acne patients: a randomized controlled trial. Dermatol Pract Concept. 2015;5(4):13–6. doi:10.5826/dpc.0504a04.
Tuong W, Wang AS, Armstrong AW. Effect of automated online counseling on clinical outcomes and quality of life among adolescents with acne vulgaris: a randomized clinical trial. JAMA Dermatol. 2015;151(9):970–5. doi:10.1001/jamadermatol.2015.0859.
Yentzer BA, Gosnell AL, Clark AR, Pearce DJ, Balkrishnan R, Camacho FT, et al. A randomized controlled pilot study of strategies to increase adherence in teenagers with acne vulgaris. J Am Acad Dermatol. 2011;64(4):793–5. doi:10.1016/j.jaad.2010.05.008.
Yentzer BA, Wood AA, Sagransky MJ, O’Neill JL, Clark AR, Williams LL, et al. An Internet-based survey and improvement of acne treatment outcomes. Arch Dermatol. 2011;147(10):1223–4. doi:10.1001/archdermatol.2011.277.
Balato N, Megna M, Di Costanzo L, Balato A, Ayala F. Educational and motivational support service: a pilot study for mobile-phone-based interventions in patients with psoriasis. Br J Dermatol. 2013;168(1):201–5. doi:10.1111/j.1365-2133.2012.11205.x.
de Korte J, Van Onselen J, Kownacki S, Sprangers MA, Bos JD. Quality of care in patients with psoriasis: an initial clinical study of an international disease management programme. J Eur Acad Dermatol Venereol JEADV. 2005;19(1):35–41. doi:10.1111/j.1468-3083.2004.01107.x.
Armstrong AW, Watson AJ, Makredes M, Frangos JE, Kimball AB, Kvedar JC. Text-message reminders to improve sunscreen use: a randomized, controlled trial using electronic monitoring. Arch Dermatol. 2009;145(11):1230–6. doi:10.1001/archdermatol.2009.269.
Armstrong AW, Idriss NZ, Kim RH. Effects of video-based, online education on behavioral and knowledge outcomes in sunscreen use: a randomized controlled trial. Patient Educ Couns. 2011;83(2):273–7. doi:10.1016/j.pec.2010.04.033.
Tuong W, Armstrong AW. Effect of appearance-based education compared with health-based education on sunscreen use and knowledge: a randomized controlled trial. J Am Acad Dermatol. 2014;70(4):665–9. doi:10.1016/j.jaad.2013.12.007.
Szabó C, Ocsai H, Csabai M, Kemeny L. A randomised trial to demonstrate the effectiveness of electronic messages on sun protection behaviours. J Photochem Photobiol B. 2015;149:257–64. doi:10.1016/j.jphotobiol.2015.06.006.
Alili ME, Vrijens B, Demonceau J, Evers SM, Hiligsmann M. A scoping review of studies comparing the Medication Event Monitoring System (MEMS) with alternative methods for measuring medication adherence. Br J Clin Pharmacol. 2016;82(1):268–79. doi:10.1111/bcp.12942.
Greenlaw SM, Yentzer BA, O’Neill JL, Balkrishnan R, Feldman SR. Assessing adherence to dermatology treatments: a review of self-report and electronic measures. Skin Res Technol Off J Int Soc Bioeng Skin. 2010;16(2):253–8. doi:10.1111/j.1600-0846.2010.00431.x.
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74.
Fialko L, Garety PA, Kuipers E, Dunn G, Bebbington PE, Fowler D, et al. A large-scale validation study of the Medication Adherence Rating Scale (MARS). Schizophr Res. 2008;100(1–3):53–9. doi:10.1016/j.schres.2007.10.029.
Geller AC, Shamban J, O’Riordan DL, Slygh C, Kinney JP, Rosenberg S. Raising sun protection and early detection awareness among Florida high schoolers. Pediatr Dermatol. 2005;22(2):112–8. doi:10.1111/j.1525-1470.2005.22204.x.
Cercato MC, Nagore E, Ramazzotti V, Sperduti I, Guillen C. Improving sun-safe knowledge, attitude and behaviour in parents of primary school children: a pilot study. J Cancer Educ Off J Am Assoc Cancer Educ. 2013;28(1):151–7. doi:10.1007/s13187-012-0413-5.
Feinstein AR. On white-coat effects and the electronic monitoring of compliance. Arch Intern Med. 1990;150(7):1377–8.
Benarous X, Legrand C, Consoli SM. Motivational interviewing use for promoting health behavior: an approach of doctor/patient relationship. La Revue de Medecine Interne. 2014;35(5):317–21. doi:10.1016/j.revmed.2013.08.009.
Gorawara-Bhat R, Gallagher TH, Levinson W. Patient-provider discussions about conflicts of interest in managed care: physicians’ perceptions. Am J Manag Care. 2003;9(8):564–71.
Molassiotis A, Morris K, Trueman I. The importance of the patient-clinician relationship in adherence to antiretroviral medication. Int J Nurs Pract. 2007;13(6):370–6. doi:10.1111/j.1440-172X.2007.00652.x.
van Netten JJ, Francis A, Morphet A, Fortington LV, Postema K, Williams A. Communication techniques for improved acceptance and adherence with therapeutic footwear. Prosthet Orthot Int. 2016;. doi:10.1177/0309364616650080.
Johnson A, Sandford J. Written and verbal information versus verbal information only for patients being discharged from acute hospital settings to home: systematic review. Health Educ Res. 2005;20(4):423–9. doi:10.1093/her/cyg141.
Johnson A, Sandford J, Tyndall J. Written and verbal information versus verbal information only for patients being discharged from acute hospital settings to home. Cochrane Database Syst Rev. 2003;4:CD003716. doi:10.1002/14651858.CD003716.
Kaskutas LA. Alcoholics anonymous effectiveness: faith meets science. J Addict Dis. 2009;28(2):145–57. doi:10.1080/10550880902772464.
Demonceau J, Ruppar T, Kristanto P, Hughes DA, Fargher E, Kardas P, et al. Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis. Drugs. 2013;73(6):545–62. doi:10.1007/s40265-013-0041-3.
Vrijens B, Belmans A, Matthys K, de Klerk E, Lesaffre E. Effect of intervention through a pharmaceutical care program on patient adherence with prescribed once-daily atorvastatin. Pharmacoepidemiol Drug Saf. 2006;15(2):115–21. doi:10.1002/pds.1198.
Vrijens B, Urquhart J, White D. Electronically monitored dosing histories can be used to develop a medication-taking habit and manage patient adherence. Expert Rev Clin Pharmacol. 2014;7(5):633–44. doi:10.1586/17512433.2014.940896.
Duhigg C. The power of habit: why we do what we do in life and business. New York: Random House Inc; 2012.
Acknowledgements
Medical writing assistance was provided by Róisín O’Connor, inScience Communications, and funded by Almirall.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure of potential conflict of interest
All authors (or their affiliated company) received honorarium from Almirall for their attendance and contribution to an Experts Meeting in Barcelona on 9 November 2015. This manuscript was initiated following this meeting, with medical writing assistance funded by Almirall. Steven R. Feldman has also lectured for Celgene, Janssen, Lilly and Novartis, and has stock in Causa Research, a Wake Forest University spin-off company developing and marketing adherence solutions. Bernard Vrijens is an employee of WestRock Healthcare. Uwe Gieler, Stefano Piaserico, Lluís Puig and Peter van de Kerkhof have no other conflicts of interest to disclose.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Feldman, S.R., Vrijens, B., Gieler, U. et al. Treatment Adherence Intervention Studies in Dermatology and Guidance on How to Support Adherence. Am J Clin Dermatol 18, 253–271 (2017). https://doi.org/10.1007/s40257-017-0253-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40257-017-0253-5